Assenagon Asset Management S.A. Blueprint Medicines Corp Transaction History

Assenagon Asset Management S.A.

$47.8 Billion
Q3 2024

A detailed history of Assenagon Asset Management S.A. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 100,633 shares of BPMC stock, worth $9.52 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

100,633

Previous 165,245 39.1%

Holding current value

$9.52 Million

Previous $17.8 Million 47.76%

% of portfolio

0.02%

Previous 0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$84.1 - $120.5 $5.43 Million - $7.79 Million	-64,612 Reduced 39.1%	100,633 $9.3 Million
Q2 2024 Jul 18, 2024	SELL	$85.18 - $108.78 $840,215 - $1.07 Million	-9,864 Reduced 5.63%	165,245 $17.8 Million
Q1 2024 Apr 24, 2024	SELL	$73.17 - $99.79 $6.92 Million - $9.44 Million	-94,549 Reduced 35.06%	175,109 $16.6 Million
Q4 2023 Jan 17, 2024	BUY	$43.96 - $92.84 $11.4 Million - $24.2 Million	260,321 Added 2788.06%	269,658 $24.9 Million
Q3 2023 Nov 06, 2023	BUY	$46.9 - $66.0 $437,905 - $616,242	9,337 New	9,337 $468,000
Q1 2023 Apr 18, 2023	BUY	$37.97 - $50.0 $517,758 - $681,800	13,636 Added 37.66%	49,847 $2.24 Million
Q4 2022 Jan 12, 2023	SELL	$41.06 - $66.48 $953,372 - $1.54 Million	-23,219 Reduced 39.07%	36,211 $1.59 Million
Q3 2022 Oct 27, 2022	SELL	$49.93 - $77.7 $19.9 Million - $31 Million	-399,376 Reduced 87.05%	59,430 $3.92 Million
Q2 2022 Jul 27, 2022	BUY	$45.23 - $70.15 $8.33 Million - $12.9 Million	184,099 Added 67.02%	458,806 $23.2 Million
Q1 2022 Apr 25, 2022	BUY	$54.1 - $110.08 $11.7 Million - $23.8 Million	216,374 Added 370.93%	274,707 $17.5 Million
Q4 2021 Feb 01, 2022	SELL	$94.25 - $115.99 $17.7 Million - $21.8 Million	-187,818 Reduced 76.3%	58,333 $6.25 Million
Q3 2021 Oct 19, 2021	SELL	$80.98 - $109.47 $1.3 Million - $1.76 Million	-16,108 Reduced 6.14%	246,151 $25.3 Million
Q2 2021 Jul 15, 2021	BUY	$82.78 - $101.0 $21.7 Million - $26.5 Million	262,259 New	262,259 $23.1 Million
Q4 2020 Feb 01, 2021	SELL	$92.08 - $124.48 $7.94 Million - $10.7 Million	-86,281 Closed	0 $0
Q3 2020 Oct 07, 2020	BUY	$66.45 - $92.7 $5.73 Million - $8 Million	86,281 New	86,281 $8 Million
Q2 2020 Jul 21, 2020	SELL	$57.09 - $79.27 $548,006 - $760,912	-9,599 Closed	0 $0
Q1 2020 Apr 17, 2020	BUY	$48.11 - $82.22 $318,055 - $543,556	6,611 Added 221.25%	9,599 $561,000
Q4 2019 Jan 17, 2020	BUY	$66.73 - $82.59 $199,389 - $246,778	2,988 New	2,988 $239,000
Q2 2019 Aug 12, 2019	SELL	$73.54 - $97.8 $1.31 Million - $1.75 Million	-17,846 Closed	0 $0
Q1 2019 Apr 26, 2019	BUY	$48.7 - $86.6 $869,100 - $1.55 Million	17,846 New	17,846 $1.43 Million

Others Institutions Holding BPMC

# of Institutions

352

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.65B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Blueprint Medicines Corp Transaction History